©The Author(s) 2019.
World J Gastrointest Oncol. Apr 15, 2019; 11(4): 322-334
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.322
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.322
Table 1 Characteristics of the whole hepatocellular carcinoma population receiving liver transplantation
| Characteristic | Total, n = 330 |
| Age (yr, range) | 56 (30-73) |
| Sex (male) | 269 (81.5%) |
| Hepatitis B carrier (%) | 81.6% |
| Waiting time from listing to transplantation (mo) | 1 (0-89) |
| MELD | 12.4 (6-59) |
| Size of tumor in explant (cm) | 3(0.25-19.5) |
| No. of tumor nodules in explant One Two Three | 163 (51.1%) 85 (26.6%) 28 (8.8%) |
| Within UCSF criteria | 75% |
| Within Milan Criteria | 65.6% |
| Serum AFP level before time of LT (ng/mL) | 18.0 (1-117850) |
| Salvage LT (%) | 71 (21.5%) |
| LDLT (%) | 204 (61.8%) |
| Microvascular invasion (%) | 97 (29.4%) |
| Well/mod differentiation (%) | 271 (84.7%) |
| Operation duration (min) | 671 |
| Blood loss (mL) | 2600 (200-30800) |
| Hospital mortality (%) | 5 (1.6%) |
| Morbidity (ClavienIIIa or above) (%) | 23.3% |
| Length of hospital stay (d) | 16 (7-378) |
| Post-transplant HCC recurrence (%) | 73 (23.9%) |
| Median disease-free survival (mo) | 60.8 (0-263) |
| Median overall survival (mo) | 65.4 (0-263) |
- Citation: Ma KW, She WH, Chan ACY, Cheung TT, Fung JYY, Dai WC, Lo CM, Chok KSH. Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population. World J Gastrointest Oncol 2019; 11(4): 322-334
- URL: https://www.wjgnet.com/1948-5204/full/v11/i4/322.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i4.322